September marks PCOS Awareness Month, and as someone who covers women's health innovation daily here at Femtech Insider - and lives with PCOS personally - it feels like the right time to examine where innovation stands in this space.
PCOS affects 1 in 15 women, making it the most common hormonal disorder in women of reproductive age. Yet 50-75% of women with the condition don't know they have it, and those seeking diagnosis see an average of 4.5 healthcare providers before getting answers.
What PCOS Actually Is (And Why That's Complicated)
PCOS - polycystic ovary syndrome - is what doctors call a syndrome, a collection of symptoms that often occur together without a single, clear cause. The name itself is misleading since not all women with PCOS actually have ovarian cysts. This has led to calls to rename the condition.
Diagnosis of PCOS requires meeting two of three criteria: Irregular periods, elevated androgen hormones, or polycystic-appearing ovaries. This immediately creates complexity - two women can have completely different symptoms yet receive identical diagnoses.
The symptom variations are significant too. Some women primarily face fertility issues and irregular cycles. Others struggle with weight gain, insulin resistance, and diabetes risk. Many also deal with acne, male-pattern hair loss, or excess body hair. Depression and anxiety are common across presentations too, but severity and triggers vary enormously.
Why Innovation Has Struggled
A physician investor once told me: "In medicine, when we classify something as a syndrome, it typically indicates our incomplete understanding of it."
And this creates fundamental problems not just for patients and providers, but also for innovators. When you don't understand what causes a condition, developing targeted treatments becomes nearly impossible. Companies struggle to design clinical trials - what endpoints do you measure when participants have vastly different presentations? Those in digital health face challenges: Which app features or services do you prioritize when some women need period tracking while others need metabolic management tools?
This complexity explains why PCOS innovation often feels generic - companies try to address everything superficially rather than going deep on specific aspects, resulting in solutions that help some women while missing others entirely.
Where Innovation Is Actually Happening
Over the past years digital health has seen the most activity. Companies like Allara Health started with PCOS-specific messaging before expanding into broader hormonal health services, offering telehealth consultations and integrated care. Similar platforms like Veera (Indian market) and Pollie provide comparable services.
The pattern is telling: Most solutions concentrate on reproductive health and weight management. While important, these represent just a fraction of how PCOS affects women's lives.
What's notable is that the supplement space is growing rapidly, with varying quality from evidence-based formulations to questionable claims. At-home testing companies promise PCOS diagnosis - often through blood tests alone, which isn't medically possible given diagnostic requirements explained earlier.
On the medtech side, there's growing interest in consumer devices for metabolic monitoring, particularly continuous glucose monitors (CGMs) given PCOS's connection to insulin resistance. Some companies are also developing procedures like ovarian ablation, with companies like May Health currently in clinical trials focusing on fertility outcomes for women with PCOS.
On the biotech side, several companies that once maintained strong PCOS programs have shifted focus to ovarian longevity, endometriosis or menopause or abandoned these pipelines entirely.
The Biggest Gap
Beyond finding a cure for the condition, one of the most significant innovation gap lies in addressing the full spectrum of PCOS symptoms that affect daily quality of life. While digital health solutions focus heavily on fertility and metabolic management, many women with PCOS struggle with dermatological symptoms, body image concerns, and the psychological impact of living with a chronic condition that affects multiple body systems.
Recent research suggests women with PCOS should be routinely assessed for mental health concerns, as the condition's varied symptoms often contribute to anxiety, depression, and social challenges. Yet solutions specifically designed to address these broader wellness and psychological aspects remain rare.
Innovation conversations tend to center on the most medically obvious symptoms while overlooking the comprehensive support many women actually need to manage the condition effectively.
The Business Reality
Most successful PCOS companies these days follow a predictable evolution: Launch with PCOS-specific messaging, then expand into broader hormonal health services, add employer benefits, and seek insurance reimbursement. It's logical business development, but sometimes dilutes deep PCOS expertise as companies chase larger markets.
The economics suggest significant opportunity. According to reserach be Allara, more than 50% of women with PCOS miss work due to their condition, 72% report negative work quality impact, and the condition costs the US healthcare system approximately $4 billion annually.
What's Still Missing
The fundamental challenge remains: PCOS isn't one condition requiring one solution, but multiple presentations needing different approaches. This demands either highly personalized platforms that adapt to individual symptom profiles, or specialized solutions that go deep on specific PCOS aspects rather than trying to address everything superficially.
We need sustained research funding to understand PCOS's underlying mechanisms, and regulatory frameworks that account for the condition's complexity rather than forcing it into traditional models designed for more straightforward diseases.
So as we mark the beginning of PCOS Awareness Month today, the goal isn't just awareness - it's translating that understanding into meaningful solutions for millions of women whose daily lives are affected by this complex, and often misunderstood condition.
